Duration of Anticoagulant Treatment after VenousThromboembolism

Publisher： Karger

E-ISSN： 1424-8840|33|5-6|354-357

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.5-6, 2005-01, pp. : 354-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 1, 2001-06 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Treatment of Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 140-142

Karger

Access to resources Recommend Favorite

Symptomatic Endpoints for Venous Thromboembolism Treatment

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 120-126

Karger

Access to resources Recommend Favorite

The Role of Ximelagatran in the Treatment of Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-04 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Treatment of venous thromboembolism: experience with bemiparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 5-6, 2003-08 ,pp. : 406-407

Karger

Access to resources Recommend Favorite